2,5-Bis(4-diethylaminophenyl)-1,3,4-oxadiazole – (1679-98-7)

1679-98-7, 2, 5-Bis(4-diethylaminophenyl)-1, 3, 4-oxadiazole, 2, 5-Bis(4'-diethylaminophenyl)-1, 3, 4-oxadiazole, EINECS 216-851-8, Benzenamine, 4, 4'-(1, 3, 4-oxadiazole-2, 5-diyl)bis[N, N-diethyl-, 4-[5-[4-(diethylamino)phenyl]-1, 3, 4-oxadiazol-2-yl]-N, N-diethylaniline, DTXSID0061878, 4-{5-[4-(diethylamino)phenyl]-1, 3, 4-oxadiazol-2-yl}-N, N-diethylaniline, 2, 5-BIS(DIETHYLAMINO)PHENYL-1, 3, 4-OXADIAZOLE, Benzenamine, 4, 4'-(1, 3, 4-oxadiazole-2, 5-diyl)bis(N, N-diethyl-, 4, 4'-(1, 3, 4-Oxadiazole-2, 5-diyl)bis(N, N-diethylaniline), 4, 4'-(1, 3, 4-oxadiazole-2, 5-diyl)bis[N, N-diethylaniline], MFCD00010070, SCHEMBL131376, DTXCID3035391, AKOS015838661, AS-66975, B1066, NS00025514, D88746, 2, 5-Bis[4-diethylaminophenyl]-1, 3, 4-oxadizole, 2, 5-Bis(4'-diethylaminophenyl)-1, 3, 4-oxdiazol, 2, 5-Bis(4-diethylaminophenyl)-1, 3, 4-oxadiazole, 98%, 2, 5-BIS(4/'-DIETHYLAMINOPHENYL)-1, 3, 4-OXADIAZOLE, N-(4-(5-[4-(Diethylamino)phenyl]-1, 3, 4-oxadiazol-2-yl)phenyl)-N, N-diethylamine #, 216-851-8